Viewing Study NCT03638167


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2025-12-31 @ 8:49 PM
Study NCT ID: NCT03638167
Status: COMPLETED
Last Update Posted: 2025-12-17
First Post: 2018-08-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Sponsor: Seattle Children's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module